AwesomeCapital
Search This Blog
Wednesday, April 8, 2020
Myriad Genetics pulls guidance amid COVID-19 headwinds
Citing COVID-19 disruptions, Myriad Genetics (NASDAQ:
MYGN
) has
withdrawn
its 2020 guidance. Shares down
2%
premarket.
https://seekingalpha.com/news/3559268-myriad-genetics-pulls-guidance-amid-covidminus-19-headwinds
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.